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Abstract
Introduction: The molecular dispersion of poorly soluble drug molecules into a polymer matrix is a popular oral drug delivery strategy known amorphization. In this type of 
molecular dispersion, the amorphous form of the drug achieves a thermodynamic solubility advantage over the crystalline form, resulting in higher bioavailability. Hot melt 
extrusion (HME) is one of two major techniques used to manufacture these amorphous solid dispersions (ASDs). Material, equipment, and process design variables contribute 
to the product performance of the ASD, and the goal of this study is to evaluate the impact of drug particle size on ASD formation. 
Methods: Physical mixtures of bicalutamide and PVPVA were prepared and analyzed using differential scanning calorimetry, and the calorimetric data was used to construct a 
temperature-composition phase diagram. The acceptable processing design space for extrusion was derived from this phase diagram and guided the preparation of 
bicalutamide-PVPVA ASDs at various temperatures and residence times. 
Results and Discussion: The extent of residual crystallinity was determined by polarized light microscopy and powder X-ray diffraction. As expected, residual crystallinity 
decreases with increasing temperature and residence times across all particle sizes. ASDs prepared with larger starting particle sizes consistently possess more residual 
crystallinity than ASDs prepared with smaller starting particle sizes. 
Conclusion: The extent of crystallinity in extruded ASDs reflect the kinetic nature of crystal dissolution in a polymer melt. 
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• 5 mL co-rotating conveying screw 
at 50 rpm
• 8 g batch size
Processing Parameters:
• Independently controlled 
operating melt temperature and 
residence time
• Temperature range: >145°C
Hot Melt Extrusion Processing & Solid State Characterization
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Negative Flory-Huggins interaction 
parameter χ indicates favorable enthalpy of 
mixing & results in melting point depression
Melting point 
depression
(a) Melting point depression is 
illustrated through DSC heat flow 
traces of various drug-polymer 
mixtures. (b) Melting point offset 
temperature is non-linear with 
respect to heating rate. (c) The 
interaction parameter χ can be 
extracted by linear regression 
analysis. (d) Temperature-
composition phase diagram of 
bicalutamide and PVPVA.
The bicalutamide/PVPVA system is highly miscible, as 
indicated by the negative interaction parameter χ=-1.53.
Approximately 50°C of melting point depression is 
observed at the 30% drug loading composition.

























Residual crystallinity decreases with increasing 
temperature and residence times across all particle sizes.
ASDs prepared with larger starting particle size material 
consistently possess more residual crystallinity than ASDs 
prepared with smaller starting particle sizes.
(a) Images of representative bicalutamide/PVPVA extrudates prepared with small and large particle size. (b) Melting and glass transition phase behavior of bicalutamide, PVPVA, 
and a representative HME ASD. (c,d) Powder X-ray diffractograms and polarized light microscopy images of materials prepared with the small (c) and large (d) particle size. (e) 
% crystallinity estimates of HME ASDs.
Two particle sizes were used to investigate the 
impact of input material attributes on the 
kinetics of ASD formation in the HME process.
Phase Diagram














Small particle size 25x increase in average particle size
20x decrease in surface area































































































(a,b) Chemical structures and SEM images of starting materials 














































































minimum processing temperature 
to form a fully amorphous system
